Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -68.1133.8294.6045.00-24.35

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is -68.11 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹161.7 Cr -5.8% 4.5% -20.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-5.8%

4.5%

-20.8%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses